glp 1 agonist tirzepatide How GLP-1 medications are transforming diabetes and weight loss treatment Compound Tirzepatide

Canadian Medical Association Journal, 196 (43), E1413

Unexpectedly, the drugs had a much-desired side-effect weight loss with little effort

But, says Levine, there is really only one medication, the stimulant lisdexamfetamine (brand name Vyvanse) that is evidence based in supporting BED

Because PWS primarily affects the brain, intranasal delivery provides a shortcut to the central nervous system while reducing systemic exposure and side effects

And even after people enroll, Milne wrote in an email to Undark, the substances short half-life would make it difficult for the researchers to ensure that participants are sticking with the trial protocol and not supplementing with gray market BPC-157